FiercePharma12h
JPM25: Bayer gears up for 'must-win battles' as Xarelto loss of exclusivity in full swing, says pharma chief
These launches belong to what Oelrich called “must-win battles” at Bayer as Xarelto loss of exclusivity reaches “full swing” ...
Bayer sees new drugs boosting return to growth in 2027, WSJ reports
Growth is on the horizon for German drug conglomerate Bayer (BAYRY), despite “falling sales of its blockbuster blood thinner Xarelto,”amid ...
Bayer attacked bureaucracy by firing some 5,000 managers and asking teams to ‘self-organize.’ Here’s how it’s going after one year
Whether ahead of their time, truly bizarre, or just plain doomed, it’s certainly interesting to see companies go completely ...
Jury says Bayer must pay $100M in trial over PCBs in Washington school
Bayer (OTCPK:BAYRY) (OTCPK:BAYZF) must pay $100M to four people who say they were sickened by exposure to toxic PCB chemicals ...
Bayer: Sell And Be Done With It
Bayer's projected earnings decline and litigation pressures affect its outlook. Find out why BAYRY stock might face ...
Cutting Middle Management: Bayer's Costly Experiment One Year Later
In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.
Bayer aims to expand presence in India with new therapies and strategic collaborations
Bayer's Global Capability Centre in Hyderabad contributes to R&D, data science, and AI-driven healthcare solutions, ...
Daily5d
Bayer seeks USFDA nod for Finerenone for adult patients with heart failure
Berlin: Bayer has announced the submission of marketing authorization applications to the U.S. Food and Drug Administration ...
Bayer Aktiengesellschaft (ETR:BAYN) Shares Up 0.4% – Here’s Why
Bayer Aktiengesellschaft (ETR:BAYN – Get Free Report) shares were up 0.4% on Wednesday . The stock traded as high as €19.99 ($20.61) and last traded at €19.79 ($20.40). Approximately 3,072,022 shares ...